ESC 365 - Single-center prospective study of accurate neo 2 in valve-in-valve TAVI: procedural and mid-to-long term outcomes

ESC2025 Premium Access

Single-center prospective study of accurate neo 2 in valve-in-valve TAVI: procedural and mid-to-long term outcomes

Session: Interventional treatment of aortic stenosis: procedure and outcome

Topic: Intervention

Speaker: Doctor G. Papadopoulos (Thessaloniki, GR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Georgios Papadopoulos

Interbalkan Medical Center, Thessaloniki (Greece)

3 presentations

0 follower

3 more presentations in this session

Periprocedural and postprocedural outcomes of patients with tricuspid aortic valve undergoing transcatheter aortic valve implantation with the myval valve

Speaker: Doctor N. Ktenopoulos (Athens, GR)

Early clinical and hemodynamic comparison of the latest-generation Evolut FX and SAPIEN 3 Ultra RESILIA Valves in transcatheter aortic valve implantation

Speaker: Doctor N. Takahashi (Tokyo, JP)

Accurate Neo prosthetic valve for percutaneous treatment of pure aortic regurgitation

Speaker: Mr L. Dominguez Rodriguez (Madrid, ES)

Access the full session

Interventional treatment of aortic stenosis: procedure and outcome

Speakers: Doctor G. Papadopoulos, Doctor N. Ktenopoulos, Doctor N. Takahashi, Mr L. Dominguez Rodriguez

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources